Does ALIROCUMAB Cause Therapy interrupted? 149 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Therapy interrupted have been filed in association with ALIROCUMAB (Praluent). This represents 0.7% of all adverse event reports for ALIROCUMAB.
149
Reports of Therapy interrupted with ALIROCUMAB
0.7%
of all ALIROCUMAB reports
2
Deaths
35
Hospitalizations
How Dangerous Is Therapy interrupted From ALIROCUMAB?
Of the 149 reports, 2 (1.3%) resulted in death, 35 (23.5%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Therapy interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALIROCUMAB. However, 149 reports have been filed with the FAERS database.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Therapy interrupted?
ADALIMUMAB (5,755)
ETANERCEPT (3,397)
RELUGOLIX (3,251)
CERTOLIZUMAB PEGOL (3,209)
LENALIDOMIDE (2,724)
UPADACITINIB (1,741)
ABATACEPT (1,726)
CLOZAPINE (1,722)
AMIKACIN (1,283)
TOFACITINIB (1,182)
Which ALIROCUMAB Alternatives Have Lower Therapy interrupted Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN